By Editor , 5 October 2026 Celaid Raises JPY400M as Shionogi, Teikoku Ventures Back US Trial Push Tokyo – October 04, 2026 -- Celaid Therapeutics Inc. has completed the second close of its Series B financing round, raising JPY 400 million (approximately USD 2.6 million) with new backing from Shionogi & Co., Ltd. and Teikoku Ventures, Inc.
